EUVIMEDEUVIMED entdecken
Crossref

SARS-CoV-2 vaccination protects against infection-induced autoantibody formation 2302309

Philip Norris, Jiashun Zheng, Aaron Bodansky, Eduard Grebe, Hasan Sulaeman, Xutao Deng, Steven Kleinman, Bryan Spencer, Sarah Reese, Clara Di Germanio, Mars Stone, Michael Busch und 1 weitere

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.1243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Philip Norris und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

SARS-CoV-2-CoV-2 infection is known to induce autoantibodies across a wide range of targets, including immune modulatory proteins and pro-thrombotic factors. It is not known if vaccination with SARS-CoV-2 mRNA vaccines would induce a similar autoantibody profile, or whether prior vaccination would protect recipients from autoantibody production upon SARS-CoV-2 infection.

Methods

Our group followed a cohort of over 65,000 blood donors across repeat donations in the COVID-19 era. We identified SARS-CoV-2 naïve donors who were infected without prior vaccination (n = 150) or were vaccinated then became infected (n = 100). We tested samples from the naïve time point and 6-10 weeks after infection (2 paired samples) or naïve then vaccination then infection (three samples) using a T7 bacteriophage array displaying 731,724 peptides (49 amino acids each) spanning the human proteome. Data were partitioned into five random groups and peptide comparisons between groups were performed using ranksum, with 80% used for training and 20% used for testing iteratively.

Results

Autoantibodies targeting 15 peptides were induced with a z-score >2 after SARS-CoV-2 infection of unvaccinated naïve donors (p < 1x10-5). Of these infection-induced autoantibodies, 1 was induced after mRNA vaccination, as well as 2 distinct vaccine induced autoantibodies. In donors who were infected after prior vaccination, autoantibody responses were blunted, targeting 7 of 15 peptides.

Conclusion

In contrast to SARS-CoV-2 infection of immunologically naïve individuals, SARS-CoV-2 mRNA vaccination induces only a limited autoantibody repertoire. Furthermore, prior vaccination protects against development of approximately half the autoantibodies induced by SARS-CoV-2 infection in this study. These data confirm the induction of autoantibodies following infection and underline both the safety of mRNA vaccines in terms of autoantibody induction, as well as potential protective effects of vaccination from COVID-19 associated autoimmunity. Funding Source NIH Topic Categories Viral Immunology (VIR)

Zitieren

APA

Norris, P., Zheng, J., Bodansky, A., Grebe, E., Sulaeman, H., Deng, X., Kleinman, S., Spencer, B., Reese, S., Germanio, C. D., Stone, M., Busch, M., & DeRisi, J. (2026). SARS-CoV-2 vaccination protects against infection-induced autoantibody formation 2302309. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1243

Vancouver

Norris P, Zheng J, Bodansky A, Grebe E, Sulaeman H, Deng X, et al. SARS-CoV-2 vaccination protects against infection-induced autoantibody formation 2302309. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1243

BibTeX
@article{Norris2026,
  author = {Norris, Philip and Zheng, Jiashun and Bodansky, Aaron and Grebe, Eduard and Sulaeman, Hasan and Deng, Xutao and Kleinman, Steven and Spencer, Bryan and Reese, Sarah and Germanio, Clara Di and Stone, Mars and Busch, Michael and DeRisi, Joseph},
  title = {SARS-CoV-2 vaccination protects against infection-induced autoantibody formation 2302309},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.1243}
}
Kostenlos starten →